Short answer
IRADIMED CORP (IRMD) filed an 8-K current report with the SEC on October 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). IRADIMED announced financial results for the quarter ended September 30, 2026.
IRADIMED CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- IRADIMED announced financial results for the quarter ended September 30, 2026
- Exhibit 99.1 contains the detailed earnings release and investor-relevant financial metrics
- Results announcement dated October 30, 2026, marking the company’s latest quarterly performance update
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $24.2M, up 14% YoY, with net income $6.5M, up 17%, signaling strong operating momentum
- 3870 pump launch gaining traction: over 70% of pump bookings were quad-stack configurations
- Gross margin 76% versus 78% YoY, reflecting manufacturing ramp costs despite improving sequentially
- Q4 revenue guidance $25.0M-$26.5M, while full-year revenue guidance narrowed to $91.6M-$93.1M
- Quarterly dividend $0.20 per share, payable November 27, 2026 to November 13 record holders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRADIMED CORP 8-K filings
Get the next IRMD 8-K as it lands
Follow IRMD for push alerts, or ask the research agent what this filing means.